Issue 86, 2017

Late stage iodination of biologically active agents using a one-pot process from aryl amines

Abstract

A simple and effective one-pot tandem procedure that generates aryl iodides from readily available aryl amines via stable diazonium salts has been developed. The operationally simple procedure and mild conditions allow late-stage iodination of a wide range of aryl compounds bearing various functional groups and substitution patterns. A novel synthetic strategy involving the preparation of nitroaryl compounds followed by a chemoselective tin(II) dichloride reduction and the use of the one-pot diazotisation–iodination transformation was also developed. The general applicability of this approach was demonstrated with the preparation of a number of medicinally important compounds including CNS1261, a SPECT imaging agent of the N-methyl-D-aspartate (NMDA) receptor and IBOX, a compound used to detect amyloid plaques in the brain.

Graphical abstract: Late stage iodination of biologically active agents using a one-pot process from aryl amines

Supplementary files

Article information

Article type
Paper
Submitted
27 Oct 2017
Accepted
26 Nov 2017
First published
01 Dec 2017
This article is Open Access
Creative Commons BY license

RSC Adv., 2017,7, 54881-54891

Late stage iodination of biologically active agents using a one-pot process from aryl amines

Nikki L. Sloan, S. K. Luthra, G. McRobbie, S. L. Pimlott and A. Sutherland, RSC Adv., 2017, 7, 54881 DOI: 10.1039/C7RA11860K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements